There may be an effective new treatment for people with bladder cancer that doesn't respond to a frontline therapy.

There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers repo ...

Protara stock surges 70% as investigational cell therapy, TARA-002, shows superior six-month efficacy in phase II bladder ...

Protara Therapeutics' TARA-002 shows promising early data in bladder cancer, with a 72% complete response rate at 6 months in ...

Eddie Jordan has spoken publicly about a "quite aggressive" bladder and prostate cancer diagnosis he received earlier this ...

Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s ...

A Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the 2024 Society of ...

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer ...

LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.

Trimodality treatment for bladder cancer in its various forms is becoming a standard option. All noncomplete responders or those who relapse in the muscle layer are salvaged via cystectomy.

There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unwieldy name of cretostimogene ...

AstraZeneca AZN announced that the FDA has accepted and granted priority review to its supplemental biologics license ...